Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations

Curr Neurol Neurosci Rep. 2019 Aug 28;19(10):77. doi: 10.1007/s11910-019-0992-1.

Abstract

Multiple sclerosis (MS) causes physical, emotional, and cognitive changes that impact function and quality of life (QoL). Risk factors for suicidality in MS patients include a high incidence of depression, increased isolation, and reduced function/independence. PURPOSE OF REVIEW: To describe the epidemiology of depression and suicidality in this population, highlight warning signs for suicidal behavior, provide recommendations and resources for clinicians, and discuss ethical decisions related to patient safety vs. right to privacy. RECENT FINDINGS: Fifty percent of MS patients will experience a major depression related to brain MRI factors and disease-related psychosocial challenges. Nevertheless, depression is under-recognized/treated. The standardized mortality ratio (SMR) indicates a suicide risk in the MS population that is twice that in the general population. Given the prevalence of depression and the increased risk of suicide in the MS population, any clinician providing care for these patients must be prepared to recognize and respond to potential warning signs.

Keywords: Depression; Multiple sclerosis; Patient management; Privacy; Suicidality; Suicide.

Publication types

  • Review

MeSH terms

  • Comorbidity
  • Depression / epidemiology*
  • Humans
  • Multiple Sclerosis / epidemiology*
  • Multiple Sclerosis / psychology*
  • Patient Safety
  • Risk Factors
  • Suicide / ethics*
  • Suicide / statistics & numerical data*